Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMEGA HEALTHCARE INVESTORS INCOHI · Entity 3362 | Director | August 07, 2026 | August 11, 2026 |
| Phreesia, Inc.PHR · Entity 2606 | Director | July 14, 2026 | July 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMEGA HEALTHCARE INVESTORS INC
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,301 |
Reported balance
After 2026-08-07 transaction · row 1
1 source rowRow 1 · 2026-08-07 · Gift · Disposed 5,131 · Balance 17,301 |
Phreesia, Inc.
Report date July 14, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,780 |
Reported balance
After 2026-07-14 transaction · row 1
1 source rowRow 1 · 2026-07-14 · Sale · Disposed 536 · Balance 37,780 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AVANOS MEDICAL, INC.
Report date July 27, 2026 · Filed July 28, 2026
Section 16 reporting ended · disclosed 2026-07-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-27 transaction · row 1
1 source rowRow 1 · 2026-07-27 · Disposition to issuer · Disposed 13,811 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-27 · Disposition to issuer · Disposed 12,003 · Balance 0 F2: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. F3: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement.
F2: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock.
F3: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2026 Filed Aug 11, 2026 20:15 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GiftCommon Stock | 5,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001873318-26-000004 · form4-08112026_040811.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,301 Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 21:35 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Disposition to issuerRestricted Share Units · Derivative | 12,003 | $25.00 | $300,075.00 |
DisclosureSEC source: 0001606498-26-000106 · wk-form4_1785274550.xml · derivative · entry 2 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,003 shares Expires not disclosed F2 · derivative.exercise_price: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. F3 · price: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 21:35 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Disposition to issuerCommon Stock | 13,811 | $25.00 | $345,275.00 |
DisclosureSEC source: 0001606498-26-000106 · wk-form4_1785274550.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 15:54 UTC | Phreesia, Inc. PHR · Entity 2606 | SaleCommon Stock | 536 | $10.70 | $5,735.20 |
DisclosureSEC source: 0001412408-26-000195 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,780 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 20:25 UTC | Phreesia, Inc. PHR · Entity 2606 | SaleCommon Stock | 2,546 | $9.53 | $24,263.38 |
DisclosureSEC source: 0001412408-26-000187 · form4.xml · nonDerivative · entry 2 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,316 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:25 UTC | Phreesia, Inc. PHR · Entity 2606 | GrantCommon Stock | 19,290 | $9.59 | $184,991.10 |
DisclosureSEC source: 0001412408-26-000187 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,862 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:15 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 3,778 | $43.67 | $164,985.26 |
DisclosureSEC source: 0001873318-26-000002 · form4-06092026_040626.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,432 F1 · shares: Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis. Read SEC document |
| May 08, 2026 Filed May 12, 2026 15:41 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantRestricted Share Units · Derivative | 12,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-26-000077 · wk-form4_1778600465.xml · derivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,003 Underlying: Common Stock · 12,003 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025. F2 · derivative.exercise_date: The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors. F2 · derivative.expiration_date: The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors. Read SEC document |
| August 08, 2025 Filed Aug 11, 2025 20:10 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | SaleCommon Stock | 2,300 | $40.16 | $92,361.79 |
DisclosureSEC source: 0001415889-25-021422 · form4-08112025_040801.xml · nonDerivative · entry 2 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,654 Read SEC document |
| August 08, 2025 Filed Aug 11, 2025 20:10 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | SaleCommon Stock | 200 | $40.16 | $8,032.00 |
DisclosureSEC source: 0001415889-25-021422 · form4-08112025_040801.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,954 Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:28 UTC | Phreesia, Inc. PHR · Entity 2606 | SaleCommon Stock | 465 | $27.64 | $12,852.60 |
DisclosureSEC source: 0001127602-25-019378 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,572 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2024. Read SEC document |
| June 26, 2025 Filed Jun 27, 2025 21:24 UTC | Phreesia, Inc. PHR · Entity 2606 | SaleCommon Stock | 2,802 | $27.67 | $77,531.34 |
DisclosureSEC source: 0001127602-25-018177 · form4.xml · nonDerivative · entry 2 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,037 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2024. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:24 UTC | Phreesia, Inc. PHR · Entity 2606 | GrantCommon Stock | 6,700 | $27.61 | $184,987.00 |
DisclosureSEC source: 0001127602-25-018177 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,839 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 25, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:05 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 4,388 | $37.60 | $164,988.80 |
DisclosureSEC source: 0001415889-25-016457 · form4-06102025_040606.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,154 F1 · shares: Represents Director compensation granted on June 6, 2025 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2026 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 18:51 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 12,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-25-000014 · wk-form4_1736189492.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,814 F1 · shares: Represents restricted share units issued to the Reporting Person on January 2, 2025 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 20:06 UTC | Phreesia, Inc. PHR · Entity 2606 | SaleCommon Stock | 1,400 | $23.03 | $32,239.20 |
DisclosureSEC source: 0001127602-24-023887 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,139 Read SEC document |
| August 13, 2024 Filed Aug 13, 2024 20:11 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | SaleCommon Stock | 1,352 | $38.00 | $51,376.00 |
DisclosureSEC source: 0001415889-24-021152 · form4-08132024_080848.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,766 Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 21:11 UTC | Phreesia, Inc. PHR · Entity 2606 | GrantCommon Stock | 8,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019415 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,539 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 26, 2025 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 19:56 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 4,605 | $32.57 | $149,984.85 |
DisclosureSEC source: 0001415889-24-016336 · form4-06112024_070613.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,118 F1 · shares: Represents Director compensation granted on June 7, 2024 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2025 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 20:09 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 8,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-24-000011 · wk-form4_1704398939.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,811 F1 · shares: Represents restricted share units issued to the Reporting Person on January 3, 2024 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:40 UTC | Phreesia, Inc. PHR · Entity 2606 | GrantCommon Stock | 5,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005913 · primarydocument.xml · nonDerivative · entry 2 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,049 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) July 13, 2024, and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:40 UTC | Phreesia, Inc. PHR · Entity 2606 | GrantCommon Stock | 5,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005913 · primarydocument.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,640 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on July 13, 2024. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:33 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 4,995 | $30.03 | $149,999.85 |
DisclosureSEC source: 0001415889-23-009387 · form4-06072023_090654.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,513 F1 · shares: Represents Director compensation via the annual grant of restricted stock which will vest on the date of the Company's 2024 Annual Meeting of Shareholders, which is approximately one (1) year from date of grant. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 00:02 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 5,131 | $29.23 | $149,979.13 |
DisclosureSEC source: 0001415889-22-006171 · form4-06062022_050651.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,518 F1 · shares: Represents Director compensation via the annual grant of restricted stock which will vest on the date of the Company's 2023 Annual Meeting of Shareholders, which is approximately one year from date of grant. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 14:09 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 3,387 | $37.37 | $126,572.19 |
DisclosureSEC source: 0001127602-21-022829 · form4.xml · nonDerivative · entry 1 Egbuonu-Davis Lisa · CIK 0001873318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,387 F1 · shares: Represents a pro rata portion of Director compensation via the annual grant elected by the reporting person to be taken as restricted stock. The restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.